Literature DB >> 3114537

[In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].

H Saito, K Sato, H Tomioka, T Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3114537

Source DB:  PubMed          Journal:  Kekkaku        ISSN： 0022-9776


× No keyword cloud information.
  6 in total

1.  Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.

Authors:  H Tomioka; K Sato; H Saito
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

2.  Postoperative osteomyelitis due to Mycobacterium fortuitum. A case report.

Authors:  T Hasegawa; R Watanabe; K Hayashi; A Inufusa; H Nakagawa
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

3.  MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.

Authors:  L B Heifets; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.

Authors:  H Saito; H Tomioka; K Sato; S Dekio
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

5.  Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.

Authors:  H Tomioka; H Saito; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.

Authors:  N Mor; J Vanderkolk; L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.